Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study "AFASAK I"

Completed

Phase N/A Results

Summary of Purpose

To compare the effects of warfarin, low-dose aspirin, or placebo on the incidence of thromboembolic complications in patients with chronic non-rheumatic atrial fibrillation.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 October 2004.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Placebo-controlled, randomized trial.

Contacts

Not available